Related Experiment Video
Updated: Aug 16, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity (Cf-PWV) to Evaluate Arterial Stiffness
Published on: May 3, 2018
[The best of hypertension in 2004]
S Laurent1, Ch Thuillez, J M Mallion
1Département de pharmacologie, INSERM 107, HEGP, Paris.
Insights
Hypertension knowledge advanced in 2004, highlighting basic science and clinical trials on lowering blood pressure. However, only 30% of patients reach blood pressure goals, necessitating improved therapeutic strategies for hypertension management.
Area of Science:
- Cardiovascular Science
- Clinical Medicine
- Pharmacology
Context:
- The year 2004 saw significant advancements in understanding hypertension.
- The Fourteenth European Society of Hypertension meeting in Paris (June 2004) was a key event.
- Progress was made in basic science, including signaling pathways related to smooth muscle tone, growth, and inflammation, particularly at the intersection of hypertension, diabetes, and metabolic syndrome.
Purpose:
- To review major developments in hypertension knowledge from 2004.
- To discuss progress in basic science and clinical trials related to hypertension.
- To address the gap between current treatment effectiveness and therapeutic goals.
Summary:
- Large clinical trials provided strong evidence for the benefits of lowering blood pressure in hypertensive patients.
- Despite progress, only about 30% of treated hypertensive patients achieve the blood pressure goal (<140/90 mmHg).
- The European Society of Hypertension meeting highlighted the need for adapted therapeutic strategies to improve blood pressure control.
Impact:
- Advances in understanding hypertension signaling pathways offer new targets for treatment.
- Clinical trial evidence reinforces the importance of blood pressure reduction in managing hypertensive diseases.
- The findings underscore the urgent need for improved therapeutic approaches to achieve better blood pressure control in a larger patient population.
Abstract:
Among the major developments of the year 2004 in the knowledge of hypertension, a special part should be dedicated to the venue in Paris of the Fourteenth meeting of the European Society of Hypertension last June. Beside major progress observed in basic science, namely signaling pathways involved in the regulation of smooth muscle tone, growth and inflammation, at the cross-road of hypertension, diabetes, and metabolic syndrome, large clinical trials have afforded strong evidence for the usefulness of lowering blood pressure in various diseases associated with hypertension. Despite these advances, the percentage of treated hypertensive patients who reach the BP goal (<140/90 mmHg) is too low (about 30%). Thus urges the need for adapting therapeutic strategies. The ESH meeting gave the opportunity to gather a large body of evidence for a better therapeutic approach, in order to control BP in a larger number of hypertensive patients.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

